Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹1,384.70
Market cap: ₹17,000 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 28.2×Sector 47.4×
Promoter holding: 74.87%+0.00% QoQ
FII holding: 5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 4 Results Update 2 Merger & Restructuring 2 Employee Stock Options 2 Board Meeting Date 2 Annual General Meeting 2 Other Announcement 1 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Jul 2026 14:20 IST BSE

Board Meeting Date

Alivus Life Sciences Board Meeting Date

Alivus Life Sciences scheduled a board meeting for July 30, 2026. The meeting aims to approve unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗

7 May 2026 19:24 IST BSE

Board Meeting Date

Alivus Life Sciences Board Meeting Date

Alivus Life Sciences scheduled a board meeting for May 14, 2026. Directors will approve annual audited results and consider a dividend recommendation for shareholders.

Read the filing ↗